Search - tctmd.com

Presenter: Jang Hoon Lee, Kyun Hee Kim, Won Suk Choi, Sun Hee Park, Myung Hwan Bae, Dong Heon Yang, Hun Sik Park, Yongkeun Cho, Shung Chull Chae, Jae Eun Jun, Myung Ho Jeong, Young Jo Kim

January 03, 2012

Advertisement

STICH Analysis by Age Shows Benefit of CABG in Ischemic Heart Failure Across the Decades

ICDs Do Not Reduce Mortality in Patients With HF Not Caused by Coronary Artery Disease: DANISH

Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI

Hemodynamics Galore: What I Learned at the C3 Summit

With Greater Uptake, ARNIs Could Potentially Save the Lives of Nearly 30,000 Patients Each Year

BioVentrix Receives CE Marking Certification for Revivent TC™, the First Minimally Invasive Heart Failure Treatment to Restore the Left Ventricle

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

St. Jude Medical Announces Launch and First US Implants of MultiPoint Pacing Technology

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Vagus Nerve Stimulation Fails to Improve Clinical Outcomes in Chronic Heart Failure

‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study

Medtronic First to Receive FDA Approval for MR-Conditional Cardiac Resynchronization Therapy-Defibrillators

Extended Follow-Up Of ANTHEM-HF Patients Shows That Benefits Of Autonomic Regulation Therapy Are Maintained After 12 Months

BioControl Medical Completes Enrollment in the INOVATE-HF Study of the CardioFit® System to Treat Heart Failure

Sorin Group Announces European Launch of REPLY CRT-P, the World’s Smallest Cardiac Resynchronization Pacemaker

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference

Early Data Show Novel Catheter-Implanted Device Benefits Patients with Left Heart Failure

The impact of revascularization and optimal medical therapy on six-month clinical outcome in patients with and without congestive heart failure after acute myocardial infarction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content